https://www.globenewswire.com/news-release/2021/05/21/2233851/0/en/Allarity-Therapeutics-Secures-Investment-from-3i-Fund-for-Recapitalization-Transition-to-Listing-on-U-S-Nasdaq-and-Advancing-Pipeline-of-Priority-Oncology-Therapeutics.html